Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Empagliflozin'

Empagliflozin published presentations and documents on DocSlides.

EMPEROR-Reduced Trial Effect of Empagliflozin on Cardiovascular
EMPEROR-Reduced Trial Effect of Empagliflozin on Cardiovascular
by damir
and Renal Events in Heart Failure With a. Reduced ...
Diabetes treatment options
Diabetes treatment options
by StarDust
Dr Theingi Aung. Endocrinologist. Royal Berkshire ...
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER212614Orig1s
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER212614Orig1s
by roy
LABELING1HIGHLIGHTS OF PRESCRIBING INFORMATIONThes...
Cardiovascular outcomes
Cardiovascular outcomes
by lois-ondreau
Silvio E Inzucchi. Professor of . Medicine. , . Y...
Fall Quality Summit d iabetes in the elderly
Fall Quality Summit d iabetes in the elderly
by bery
. Michael Shannon, . MD. Endocrinologist . and PSW...
Empagliflozin in Heart
Empagliflozin in Heart
by brooke
. Failure. . with. a . Preserved. Ejection Frac...
Beyond A1c: Exploring the Expanding Role of Anti-Diabetic Agents
Beyond A1c: Exploring the Expanding Role of Anti-Diabetic Agents
by deena
Saidee Oberlander, PharmD, BCPS. Acute Care Pharma...
Updates on CVOT Data and Clinical Comparisons That Matter
Updates on CVOT Data and Clinical Comparisons That Matter
by pamella-moone
This program will include a discussion of off-lab...
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
Emerging CV Outcomes Trial Results: What Do They Mean for T2D Management?
by tatyana-admore
Expert Panelists. Program Goals. Evaluating CV Ri...
CV Risk Management in T2DM: What Did We Learn From EASD 2016?
CV Risk Management in T2DM: What Did We Learn From EASD 2016?
by marina-yarberry
Program Overview. EMPA-REG OUTCOME: Trial Design....
New Drug Update 2016 A Formulary Approach
New Drug Update 2016 A Formulary Approach
by test
J. Russell May, Pharm.D., FASHP. Clinical Profess...